William K Heiden - Net Worth and Insider Trading
William K Heiden Net Worth
The estimated net worth of William K Heiden is at least $7 Million dollars as of 2024-09-20. William K Heiden is the President & CEO of AMAG Pharmaceuticals Inc and owns about 490,056 shares of AMAG Pharmaceuticals Inc (AMAG) stock worth over $7 Million. William K Heiden is also the Director of Atara Biotherapeutics Inc and owns about 8,360 shares of Atara Biotherapeutics Inc (ATRA) stock worth over $66,295. Details can be seen in William K Heiden's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that William K Heiden has not made any transactions after 2023-11-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of William K Heiden
William K Heiden Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, William K Heiden owns 3 companies in total, including Atara Biotherapeutics Inc (ATRA) , AMAG Pharmaceuticals Inc (AMAG) , and Macrogenics Inc (MGNX) .
Click here to see the complete history of William K Heiden’s form 4 insider trades.
Insider Ownership Summary of William K Heiden
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ATRA | Atara Biotherapeutics Inc | 2023-11-10 | director |
AMAG | AMAG Pharmaceuticals Inc | 2020-03-02 | director & President & CEO |
MGNX | Macrogenics Inc | 2022-05-23 | director |
William K Heiden Latest Holdings Summary
William K Heiden currently owns a total of 2 stocks. Among these stocks, William K Heiden owns 490,056 shares of AMAG Pharmaceuticals Inc (AMAG) as of May 9, 2019, with a value of $7 Million and a weighting of 99.03%. William K Heiden also owns 8,360 shares of Atara Biotherapeutics Inc (ATRA) as of November 10, 2023, with a value of $66,295 and a weighting of 0.97%.
Latest Holdings of William K Heiden
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
AMAG | AMAG Pharmaceuticals Inc | 2019-05-09 | 490,056 | 13.75 | 6,738,270 |
ATRA | Atara Biotherapeutics Inc | 2023-11-10 | 8,360 | 7.93 | 66,295 |
Holding Weightings of William K Heiden
William K Heiden Form 4 Trading Tracker
According to the SEC Form 4 filings, William K Heiden has made a total of 0 transactions in AMAG Pharmaceuticals Inc (AMAG) over the past 5 years. The most-recent trade in AMAG Pharmaceuticals Inc is the acquisition of 10,000 shares on May 9, 2019, which cost William K Heiden around $107,000.
According to the SEC Form 4 filings, William K Heiden has made a total of 1 transactions in Atara Biotherapeutics Inc (ATRA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Atara Biotherapeutics Inc is the acquisition of 4,000 shares on November 10, 2023, which cost William K Heiden around $25,000.
Insider Trading History of William K Heiden
- 1
William K Heiden Trading Performance
GuruFocus tracks the stock performance after each of William K Heiden's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by William K Heiden is 124.71%. GuruFocus also compares William K Heiden's trading performance to market benchmark return within the same time period. The performance of stocks bought by William K Heiden within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how William K Heiden's insider trading performs compared to the benchmark.
Performance of William K Heiden
William K Heiden Ownership Network
William K Heiden Owned Company Details
What does Atara Biotherapeutics Inc do?
Who are the key executives at Atara Biotherapeutics Inc?
William K Heiden is the director of Atara Biotherapeutics Inc. Other key executives at Atara Biotherapeutics Inc include EVP & Global Head RA & Quality Jill Henrich , SVP & GC & Secretary Amar Murugan , and director & President and CEO Pascal Touchon .
Atara Biotherapeutics Inc (ATRA) Insider Trades Summary
Over the past 18 months, William K Heiden made 1 insider transaction in Atara Biotherapeutics Inc (ATRA) with a net purchase of 100,000. Other recent insider transactions involving Atara Biotherapeutics Inc (ATRA) include a net sale of 204,620 shares made by Pascal Touchon , a net sale of 68,971 shares made by Amar Murugan , and a net sale of 64,459 shares made by Eric J Hyllengren .
In summary, during the past 3 months, insiders sold 8,050 shares of Atara Biotherapeutics Inc (ATRA) in total and bought 0 shares, with a net sale of 8,050 shares. During the past 18 months, 27,448 shares of Atara Biotherapeutics Inc (ATRA) were sold and 32,673 shares were bought by its insiders, resulting in a net purchase of 5,225 shares.
Atara Biotherapeutics Inc (ATRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Atara Biotherapeutics Inc Insider Transactions
William K Heiden Mailing Address
Above is the net worth, insider trading, and ownership report for William K Heiden. You might contact William K Heiden via mailing address: C/o Amag Pharmaceuticals, Inc., 1100 Winter Street, Waltham Ma 02451.